A one year anticipated blood transfusion requirements among patients with acute leukemia undergoing chemotherapy in the National Center of Hematology in Baghdad

被引:5
作者
Alwan, Alaa Fadhil [1 ]
Alrahal, Nidal Kareem [2 ]
Alnuaimi, Maha Abdul-Jabbar [3 ]
机构
[1] Mustansiriyah Univ, Dept Clin Hematol, Natl Ctr Hematol, Baghdad, Iraq
[2] Mustansiriyah Univ, Dept Lab Dept, Natl Ctr Hematol, Apheresis Unit, Baghdad, Iraq
[3] Mustansiriyah Univ, Coll Med, Dept Community Med, Baghdad, Iraq
关键词
Acute leukemia; blood transfusion; requirement; ACUTE MYELOID-LEUKEMIA; MANAGEMENT; DIAGNOSIS; SURVIVAL; CARE; CELL;
D O I
10.4103/ijh.ijh_12_18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Acute leukemia is considered one of the most diseases that required frequent blood transfusion. Despite that blood transfusion is one of the main parts in the supportive management of acute leukemia patients, still, there are few data showing the exact requirements in regard to blood components for those patients. OBJECTIVES: The aims of this study were to review the predicted amount of blood transfusions needed for a patient with acute leukemia under a regimen of chemotherapy and to verify the transfusion frequency practices, according to the types of acute leukemia, levels of treatment, prognosis, and other demographic factors. MATERIALS AND METHODS: A prospective cohort study conducted at the National Center of Hematology/Mustansiriyah University from January 2013 to January 2015. Thirty newly diagnosed patients were enrolled in this study. The inclusion criteria included newly diagnosed acute leukemia whether lymphoid or myeloid except acute promyelocytic leukemia (M3) patients who were excluded. All patients subjected to detailed history and routine hematological investigations. They were followed up and assessed during induction and consolidation phases for both disease entities. RESULTS: Thirty patients were included in this study; 20 were male and 10 were female. The mean age was 31.4 years, ranging from 15 to 66 years. There were 15 cases of AML and 15 cases for ALL. The number of transfused units was found to be higher and statistically significant in those below 40 years of age, male patients and in patients with complete remission, while it was not significant for type of disease. CONCLUSION: This study provides information to estimate the anticipated requirements for blood transfusion for those patients in regard to different factors which can be considered as guideline for these tertiary centers for accurate assessment of transfusion requirements and to direct resources for better outcome.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 13 条
  • [1] Prognostic effect of blood transfusion in children with acute lymphoblastic leukemia
    Alkayed, Khaldoun
    Al Hmood, Ammar
    Madanat, Faris
    [J]. BLOOD RESEARCH, 2013, 48 (02) : 133 - 138
  • [2] Platelet transfusion and survival in adults with acute leukemia
    Blumberg, N.
    Heal, J. M.
    Liesveld, J. L.
    Phillips, G. L.
    Rowe, J. M.
    [J]. LEUKEMIA, 2008, 22 (03) : 631 - 635
  • [3] Transfusion dependency at diagnosis and transfusion intensity during initial chemotherapy are associated with poorer outcomes in adult acute myeloid leukemia
    Cannas, Giovanna
    Fattoum, Jihane
    Raba, Michel
    Dolange, Helene
    Barday, Gregory
    Francois, Marion
    Elhamri, Mohamed
    Salles, Gilles
    Thomas, Xavier
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1797 - 1806
  • [4] Supportive care in patients with acute leukaemia: historical perspectives
    Cannas, Giovanna
    Thomas, Xavier
    [J]. BLOOD TRANSFUSION, 2015, 13 (02) : 205 - 220
  • [5] Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?
    Dawson, Mark A.
    Avery, Sharon
    McQuilten, Zoe K.
    Bailey, Michael J.
    Shortt, Jake
    Polizzotto, Mark N.
    Wood, Erica M.
    Cole-Sinclair, Merrole F.
    [J]. HAEMATOLOGICA, 2007, 92 (07) : 996 - 997
  • [6] Red blood cell transfusion triggers in acute leukemia: a randomized pilot study
    DeZern, Amy E.
    Williams, Katherine
    Zahurak, Marianna
    Hand, Wesley
    Stephens, R. Scott
    King, Karen E.
    Frank, Steven M.
    Ness, Paul M.
    [J]. TRANSFUSION, 2016, 56 (07) : 1750 - 1757
  • [7] New insights in the management of elderly patients with acute myeloid leukemia
    Dombret, Herve
    Raffoux, Emmanuel
    Gardin, Claude
    [J]. CURRENT OPINION IN ONCOLOGY, 2009, 21 (06) : 589 - 593
  • [8] STUDY OF BLOOD UTILIZATION BY DIAGNOSIS, MONTH OF TRANSFUSION, AND GEOGRAPHIC REGION OF THE UNITED-STATES
    FRIEDMAN, BA
    BURNS, TL
    SCHORK, MA
    [J]. TRANSFUSION, 1979, 19 (05) : 511 - 525
  • [9] Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience
    Schellongowski, Peter
    Staudinger, Thomas
    Kundl, Michael
    Laczika, Klaus
    Locker, Gottfried J.
    Bojic, Andja
    Robak, Oliver
    Fuhrmann, Valentin
    Jaeger, Ulrich
    Valent, Peter
    Sperr, Wolfgang R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 231 - 237
  • [10] Anemia Management in Oncology and Hematology
    Spivak, Jerry L.
    Gascon, Pere
    Ludwig, Heinz
    [J]. ONCOLOGIST, 2009, 14 : 43 - 56